AppsFromResearch
SCI Cancer Clinical Trials icon

SCI Cancer Clinical Trials

Evidence Tier:VALIDATED

Initial evidence from research studies

For:Researchers & AcademicsClinicians & Healthcare ProfessionalsPatients & Caregivers

App Summary

SCI Cancer Clinical Trials is a reference tool designed to help patients and clinicians search for and connect with actively recruiting cancer clinical trials at the Stanford Cancer Institute. The associated research describes the implementation of the underlying clinical trial matching system, which increased screening referrals from 20 in its first year to 236 in its third year, with 16-26% of referred patients ultimately enrolling. The authors conclude that such systems can increase awareness of available trials and provide a mechanism to improve clinical trial accrual.

App Screenshots

SCI Cancer Clinical Trials screenshot 1 of 10SCI Cancer Clinical Trials screenshot 2 of 10SCI Cancer Clinical Trials screenshot 3 of 10SCI Cancer Clinical Trials screenshot 4 of 10SCI Cancer Clinical Trials screenshot 5 of 10SCI Cancer Clinical Trials screenshot 6 of 10SCI Cancer Clinical Trials screenshot 7 of 10SCI Cancer Clinical Trials screenshot 8 of 10SCI Cancer Clinical Trials screenshot 9 of 10SCI Cancer Clinical Trials screenshot 10 of 10

Detailed Description

Functionality & Mechanism Developed by the Stanford Cancer Institute, this tool provides a searchable interface for over 250 active cancer clinical trials. The system facilitates trial discovery by cancer condition or keyword search. Core functionality permits users to transmit trial information via email and initiate direct communication with specific trial coordinators or the central Cancer Clinical Trials Office to inquire about participation. The interface is designed for rapid information retrieval and connection to research staff.

Evidence & Research Context

  • The app provides public access to trials managed within an institutional framework designed to improve participant screening and enrollment.
  • Associated research details the development of a related, EMR-integrated clinical trial matching system for healthcare providers at Stanford.
  • Implementation of the provider-facing system demonstrated a significant increase in screening referrals over three years, from 20 to 236 annually.
  • The conversion rate for these system-facilitated referrals, defined as subsequent trial enrollment, was documented between 16% and 26%.

Intended Use & Scope This application is intended as a clinical reference tool for patients, caregivers, and clinicians to identify potentially relevant trials at the Stanford Cancer Institute. Its primary utility is for information discovery. The tool does not assess eligibility, provide medical advice, or constitute enrollment. Formal screening must be initiated directly with the trial's research team.

Studies & Publications

1 publication

Peer-reviewed research associated with this app.

Effectiveness/Outcome Study

Development and implementation of cancer clinical trial patient screening using an electronic medical record-integrated trial matching system

Bui et al. (2025) · BMJ Health & Care Informatics

Trial screening referrals increased more than tenfold over three years with consistent enrollment conversion.

Objectives Clinical trial enrolment is critical for the development and approval of novel cancer therapeutics, but patient identification and recruitment to clinical trials remains low and multiple trials accrue slowly or fail to meet accrual goals. Informatics solutions may facilitate clinical trial screening, ideally improving patient engagement and enrolment. Our objective is to develop and implement a system to efficiently screen queried patients for available clinical trials. Methods At Stanford, we designed and implemented a personalised clinical trial matching system, integrating our electronic medical record, clinical trials management system and a third-party software-based solution to directly connect providers with clinical research coordinators and appropriate trials. Results Over 3 years of a staged rollout, significant increases in clinical trial screening requests and subsequent enrolment have been observed. The total number of screening referrals increased from 20 in the first year to 236 in the third year. Enrolment related to screening referrals, the 'conversion rate', ranged from 16% to 26% of referred patients. Conclusion Clinical trial matching systems can increase awareness of available trials and provide a mechanism to increase clinical trial accrual, especially when implemented at the point of care for easy access at treatment decision points. Here, we describe the process of creating and implementing a bespoke clinical trial matching software integrated into the electronic medical record. Having validated the utility of the platform, we will focus on further efforts to drive utilisation through software features.
... Read More

SCI Cancer Clinical Trials

Free